RUNX2 and cancer: The expression of RUNX1 was increased relative to that in the normal tissues in 17 of 33 cancers, showing a decrease only in 1 cancer (Figure S1A); the expression of RUNX2 was elevated relative to that in the normal tissues in 11 of 33 cancers and decreased in 2 cancers (Figure S1B), and the expression of RUNX3 was increased in 17 of 33 cancers and decreased in 2 cancers relative to that in the normal tissues (Figure S1C).